Together is a new resource for anyone affected by pediatric cancer - patients and their parents, family members, and friends.Learn More
Asparaginase Erwinia chrysanthemi (recombinant)
Recombinant Erwinia asparaginase (Rylaze®) is a type chemotherapy. It works by slowing or stopping the growth of cells. It is used in combination with other medicines. This medicine is given to patients who have had reactions to similar drugs such as calaspargase (Asparlas), asparaginase (Elspar®), or pegaspargase (Oncaspar®).
The care team will watch your child closely for signs of an allergic reaction. Your child will have regular tests to check blood counts, blood clotting factors, pancreatic enzymes, blood sugar, liver function, and kidney function.
Given as an injection (shot) into a muscle
Allergic Reaction: Symptoms of an allergic reaction may include hives, rash, itching, and difficulty breathing or swallowing.
Not all patients who take this medicine will have these side effects. Common side effects are in bold, but there may be others. Please report any symptoms or side effects to your doctor or pharmacist. Find more information on side effects.
Be sure to discuss all questions and instructions with your doctor or pharmacist.